High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
Open Access
- 31 October 2004
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 11 (10) , 1445-1453
- https://doi.org/10.1016/j.chembiol.2004.08.011
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocolRespirology, 2004
- HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirusBiochemical and Biophysical Research Communications, 2004
- Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore PointsJournal of Chemical Information and Computer Sciences, 2004
- Serpin Mechanism of Hepatitis C Virus Nonstructural 3 (NS3) Protease InhibitionPublished by Elsevier ,2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruziBiochemical and Biophysical Research Communications, 2002
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 1. Michael Acceptor Structure−Activity StudiesJournal of Medicinal Chemistry, 1998
- Hyperexpression of a synthetic gene encoding a high potential iron sulfur proteinProtein Engineering, Design and Selection, 1994